The notices it replaced
- Reissues: PA-21-260 PHS 2021-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- 2 steps back: PA-20-262 PHS 2020-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- 3 steps back: PA-19-273 PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required
- 4 steps back: PA-18-573 PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
Replaced by PA-23-231.
Who won it before
379 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $254,685,614 in first-year total cost, median $674,883.
Most frequent study sections
- Special Emphasis Panel[ZRG1 RPHB-Z (10)]45
- Special Emphasis Panel[ZRG1 RPHB-Y (12)]43
- Special Emphasis Panel[ZRG1 RPHB-D (16)]20
- Special Emphasis Panel[ZRG1 SCIL-D (10)]18
- Special Emphasis Panel[ZRG1 CCHI-J (10)]15
Most frequent institutions
- OREGON RES BEHAVIORAL INTERVENTION STRAT11
- MINNESOTA HEALTHSOLUTIONS CORPORATION10
- ISA ASSOCIATES, INC.7
- FLINT REHABILITATION DEVICES5
- POSIT SCIENCE CORPORATION5
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Preventing Post-Thrombotic Syndrome after Deep Vein Thrombosis with Perivascular Anti-Inflammatory Agent Delivery2R44HL160434-02 | SEWARD, KIRK | MERCATOR MEDSYSTEMS, INC., CA | $1,636,379 | ZRG1 |
| 2024 | Placement Success Predictor: Using Site-Customized Machine Learning Models to Predict the Best Level of Care Placement for Each Child's Behavioral Health Needs2R44MH125486-02A1 | TRUDEAU, KIMBERLEE JEAN | OUTCOME REFERRALS INC, MA | $1,110,421 | ZRG1 |
| 2024 | Long-acting PTH for hypoparathyroidism1R44DK138647-01 | HALES, LAURA M | EXTEND BIOSCIENCES, INC., MA | $999,615 | ZRG1 |
| 2024 | A NOVEL PRECISION MEDICINE APPROACH FOR OBESITY: A RANDOMIZED, MULTI-CENTER TRIAL1R44DK138619-01 | BAGNALL, MARK | PHENOMIX SCIENCES, LLC, CA | $996,003 | ZRG1 |
| 2024 | Phase 1 Safety, Pharmacokinetic study followed by Phase 2a Proof-of-Concept study of AVR-48, a small molecule macrophage modulator to prevent bronchopulmonary dysplasia in neonates1R44HD112276-01A1 | ACHARYA, SUCHISMITA | AYUVIS RESEARCH, INC., TX | $895,365 | ZRG1 |
| 2024 | Remote Observed Methadone Evaluation Phase II (ROME II): Retention and Costs of Care2R44DA056259-02 | DENNIS, MICHAEL L.GILES, MICHAEL | SONARA HEALTH INC, TX | $812,322 | ZRG1 |
| 2024 | Computer Guided Microwave Liver Ablation1R44CA287803-01 | BORSIC, ANDREA | NE SCIENTIFIC, INC., MA | $603,206 | ZRG1 |
| 2024 | Phase IIB Clinical and Nonclinical Testing of Soft Spring Continence Pessary for Women, in Support of FDA 510(k) Clearance Requirements2R44HD105574-03 | ROBERTS, MELODY ANN | LIV LABS INC., IL | $563,008 | ZRG1 |
| 2024 | Bridges: A digital intervention to increase workplace belonging1R43MD019197-01 | EVERS, KERRY | PRO-CHANGE BEHAVIOR SYSTEMS, INC., RI | $324,381 | ZRG1 |
| 2024 | Effective Newborn Community-Outreach Recovery Engagement (ENCORE) - a culturally appropriate professional development course for community health workers1R43MD019206-01 | COOPER, DEXTER L | KDH RESEARCH AND COMMUNICATION, INC., GA | $297,083 | ZRG1 |
| 2024 | BRITE 2.0: A just-in-time adaptive intervention for suicide safety planning in adolescents1R44MH135605-01 | ALLEN, NICHOLAS B | KSANA HEALTH, INC., OR | $295,504 | ZRG1 |
| 2024 | SPIRIT Club CBI Pathway: A novel streaming platform for physical activity and wellness promotion for chronic brain injury survivors1R44HD112248-01A1 | CINER, JARED PHILLIP | SPIRIT FIT & HEALTH INC, MD | $275,699 | ZRG1 |
| 2023 | Validation of artificial intelligence (AI) based software as medical device (SaMD) for retinopathy of prematurity (ROP)1R44EY035596-01 | CAMPBELL, JOHN PETERJONAS, KARYN | SILOAM VISION, INC., OR | $1,907,135 | ZRG1 |
| 2023 | The first clinical use of the BiVACOR Total Artificial Heart1R44HL167582-01A1 | TIMMS, DANIEL | BIVACOR, INC., TX | $1,569,477 | ZRG1 |
| 2023 | Advanced Contingency Management System for Reduction of Alcohol Use.1R44AA030948-01 | JOHNSON, RON KIMBERLYMCDONELL, MICHAEL GMCPHERSON, STERLING M | MANAGED HEALTH CONNECTIONS, LLC, WA | $1,398,716 | ZRG1 |
| 2023 | Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleotide Salvage Pathway to Treat Underserved Tumor Types1R44CA281485-01 | SCHULTZ, KENNETH | TRETHERA CORPORATION, CA | $1,349,805 | ZRG1 |
| 2023 | Eliminating Ventricular Tachycardia: Pivotal Clinical Trial using the Durablate® Catheter1R44HL169112-01A1 | CURLEY, MICHAEL G | THERMEDICAL, INC., MA | $1,342,339 | ZRG1 |
| 2023 | Development of the Couplet Care Bassinet to support safe implementation of skin-to-skin contact and rooming-in on postnatal units2R44HD097017-02A1 | MCENTYRE, STACIETOMORI, CECILIATULLY, KRISTIN PATRICIA | COUPLET CARE, LLC, NC | $1,341,487 | ZRG1 |
| 2023 | Development of a novel small molecule MDM2 inhibitor for innovative sarcoma treatment1R44CA281622-01 | HANNA, GABI | LAMASSU BIO INC, NC | $1,304,141 | ZRG1 |
| 2023 | Noninvasive prediction of skin precancer severity using in vivo cellular imaging and deep learning algorithms.1R44CA285138-01 | SANCHEZ, GABRIEL NESTOR | ENSPECTRA HEALTH, INC., CA | $1,291,948 | ZRG1 |
| 2023 | Automated Long-Term Oxygen Therapy Control System2R44HL160356-02A1 | RYDBERG, NICK | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $1,279,500 | ZRG1 |
| 2023 | An Open-Labeled, Single Arm Phase 2 Efficacy and Safety Study of REM-001 Photodynamic Therapy (PDT) for Treatment of Cutaneous Metastatic Breast Cancer (CMBC)1R44CA281615-01 | BROWN, DENNIS | KINTARA THERAPEUTICS, INC., CA | $1,254,180 | ZRG1 |
| 2023 | Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants1R44DC020684-01A1 | KOCH, DEAN RMAITRE, NATHALIE | THRIVE NEUROMEDICAL, LLC, OH | $1,191,469 | ZRG1 |
| 2023 | LIGHTSITE IIIB: Clinical Evaluation of Photobiomodulation (PBM) in dry AMD Patients2R44EY025508-04 · under PA-21-260 | TEDFORD, CLARK E | LUMITHERA, INC., WA | $1,169,339 | ZRG1 |
| 2023 | The Development of a Bimodal Walking-Running Prosthetic Foot1R44HD113432-01 | JOHANSSON, JENNIFER LYNNE | LIBERATING TECHNOLOGIES, INC., MA | $1,142,863 | ZRG1 |
| 2023 | Cognitive Behavioral Immersion: A Randomized Control Trial of Peer-Based Coaching in the Metaverse2R44MH132202-02A1 | ROBINSON, NOAH | VERY REAL HELP, LLC, TN | $1,125,395 | ZRG1 |
| 2023 | Antimicrobial dermal matrices to promote infection free wound closure in DTU-DFUs.1R44DK137730-01 | MEHTA, MANAV | GEL4MED, INC., MA | $1,119,996 | ZRG1 |
| 2023 | Cannabidiol/Palmitoylethanolamide sublingual tablets for the treatment of Painful Diabetic Peripheral Neuropathy1R44DK136492-01A1 | ABDI, SALAHADINKIMLESS, DEBRAWALLACE, MARK S | PURE GREEN PHARMACEUTICALS, INC., MI | $1,118,712 | ZRG1 |
| 2023 | Access-H20: Sensor driven smart faucet to enable and empower independent drinking and grooming for individuals impacted by spinal cord injury2R44HD108061-02 | JENG, HUEIWANG ANNA COOKWADDELL, JOHN STEVEN | NASONI LLC, VA | $1,068,492 | ZRG1 |
| 2023 | SmartAssist™: Adaptive robotic assistance to maximize patient engagement with the Barrett Upper-Extremity Robotic Trainer (Burt)1R44HD109106-01A1 | BLACK-SCHAFFER, RANDIEMCDONALD, CRAIG | BARRETT TECHNOLOGY, LLC, MA | $1,049,104 | ZRG1 |
| 2023 | SIBTime: Media-enhanced Technology for Promoting the Behavioral Health and Family Relationships of Typically Developing Young Siblings2R44MD015947-02 | MARQUEZ, JESSIEMETZLER, CAROL WVADASY, PATRICIA F | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $1,029,677 | ZRG1 |
| 2023 | A Personalized Digital Intervention Program to Reduce Exposure to Endocrine Disrupting Chemicals among a Child-Bearing Age Cohort2R44ES034312-02 | HUA, JENNA | MILLION MARKER WELLNESS INC., CA | $1,028,322 | ZRG1 |
| 2023 | Development and evaluation of a multi-media training program for elementary school bullying and abuse prevention: radKIDS 2.02R44MD015695-02 | JOHNSON-SHELTON, DEBORAH | SAAVSUS, INC., OR | $1,011,502 | ZRG1 |
| 2023 | R-5280, A Novel Modified Superior Resistant Starch Therapy for Type 1 Diabetes1R44DK137649-01 | FANGER, GARYFURLAN FREGUIA, CHRISTIAN | RISE THERAPEUTICS, LLC, MD | $1,000,000 | ZRG1 |
| 2023 | A Phase 2, randomized, double-blind, 4-arm, multicenter study to demonstrate the efficacy and safety of topical dosage formulations of a prescription drug product for actinic keratosis1R44CA288166-01 | ISAACMAN, STEVEN | NANOMETICS, LLC, CA | $1,000,000 | ZRG1 |
| 2023 | 7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors1R44CA285207-01 | LEWIS, LIONEL DAVIDMARATHI, UPENDRASCHARY, WILLIAM | 7 HILLS PHARMA, LLC, TX | $999,200 | ZRG1 |
| 2023 | Bloomer Augmented Garment Platform-Barrier Removal for women in cArdiac rehab (BRA)1R44HL169065-01 | CHONG, ALICIA | BLOOMER HEALTH TECH INC, MA | $998,904 | ZRG1 |
| 2023 | Contact Pathway Inhibitor to Prevent Vascular Access Failure1R44HL167467-01 · under PA-21-260 | LORENTZ, CHRISTINA UTUCKER, ERIK IAN | ARONORA, INC., OR | $998,549 | ZRG1 |
| 2023 | Non-surgical treatment option for pelvic organ prolapse2R44HD097809-04A1 | HANISSIAN, PAUL | REIA, LLC, NH | $994,718 | ZRG1 |
| 2023 | Mindfulness Based Stress Reduction App for African American Caregivers2R44AG071168-02 | ALEXANDER, KARENCARSWELL, STEVEN BERNARD | COG ANALYTICS, LLC, MD | $992,382 | ZRG1 |
| 2023 | A Web-based Digital Health Portal for Practitioners to Improve Clinical Care and Patient Outcomes for Upper-limb Myoelectric Prosthesis Wearers1R44HD110334-01A1 | WRIGHT, ZACHARY | COAPT, LLC, IL | $986,865 | ZRG1 |
| 2023 | Respiratory Oxygen Adherence Monitor for COPD Patients2R44HL147667-02A1 | KREPKOVICH, EILEEN T. | BARRON ASSOCIATES, INC., VA | $939,577 | ZRG1 |
| 2023 | Development of ALM-488 for nerve and ureter visualization during abdominal surgery1R44CA275546-01A1 | BERMAN, BRETT J.WHITNEY, MICHAEL A | ALUME BIOSCIENCES, INC., CA | $937,219 | ZRG1 |
| 2023 | An online professional development course to train CHWs to provide oral health outreach to low-income Black guardians2R44MD016352-02 | COOPER, DEXTER L | KDH RESEARCH AND COMMUNICATION, INC., GA | $933,473 | ZRG1 |
| 2023 | A conversational agent to support remote care for individuals with substance use disorder2R44DA050218-02 | HO, Y. XIANJACKSON, JONATHAN LEE | DIMAGI, INC., MA | $927,938 | ZRG1 |
| 2023 | Phase IIB Plasticity-based Adaptive Cognitive Remediation for Alzheimers Disease2R44AG047722-07 · under PA-21-260 | LEE, HYUN KYU | POSIT SCIENCE CORPORATION, CA | $924,904 | ZRG1 |
| 2023 | Spinal Cord Innovation in Pediatrics to Treat Cerebral Palsy (SCiP Clinical Study)1R44HD112281-01A1 | GAD, PARAG | SPINEX, INC., CA | $924,592 | ZRG1 |
| 2023 | Intuitive Child Safety Seat to Increase Security2R44HD097846-02 | SEIFERT, SARA | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $922,259 | ZRG1 |
| 2023 | Mucoadhesive film for the treatment of vestibulodynia1R44HD112245-01 | BENHABBOUR, SOUMYA RAHIMAGELLER, ELIZABETHGUTHRIE, KATE MJANUSZIEWICZ, RIMA | ANELLEO, INC., NC | $891,877 | ZRG1 |
| 2023 | XCSITE 300: Cloud-Enabled Closed-Loop Transcranial Current Stimulation Device for At-Home Studies2R44MH119872-03 | TOWNSEND, LEAH BISHOP | PULVINAR NEURO LLC, NC | $886,440 | ZRG1 |
| 2023 | Knee-Biofeedback Rehabilitation Interface for Game-based Home Therapy (KneeBRIGHT)2R44AG062069-04A1 · under PA-21-260 | KREPKOVICH, EILEEN T. | BARRON ASSOCIATES, INC., VA | $885,288 | ZRG1 |
| 2023 | Amino Acids and Pediatric Hepatic Steatosis1R44DK135312-01A1 | WOLFE, ROBERT R | AMINO COMPANY LLC, THE, DE | $883,007 | ZRG1 |
| 2023 | Regulatory clearance of the Glide Control Strategy for Upper Limb Prostheses2R44HD090811-04A1 · under PA-21-260 | KALIKI, RAHUL REDDY | INFINITE BIOMEDICAL TECHNOLOGIES, LLC, MD | $873,316 | ZRG1 |
| 2023 | Remote Monitoring and Detecting of Tardive Dyskinesia for Improving Patient Outcomes2R44MH114763-02A1 · under PA-21-260 | STERNS, ANTHONY | IRX REMINDER, LLC, OH | $871,153 | ZRG1 |
| 2023 | Developing and testing the Opioid Rapid Response System2R44DA053078-02 | CHOI, HYE JEONGHECHT, MICHAEL | REAL PREVENTION, LLC, NJ | $858,761 | ZRG1 |
| 2023 | Evaluation of a mobile app-based video Directly Observed Therapy (video DOT) intervention for medication adherence in pediatric heart transplant patients1R44HL167591-01A1 · under PA-21-260 | GUPTA, DIPANKARSEIGUER, SEBASTIAN | EMOCHA MOBILE HEALTH, INC., MD | $838,636 | ZRG1 |
| 2023 | Novel Post-surgical Incision Management Device to Prevent Ostomy Complications1R44DK131766-01A1 · under PA-21-260 | OBST, ANDREW T | FISTULA SOLUTION CORPORATION, MN | $773,063 | ZRG1 |
| 2023 | GEMINI: Virtual Integrative Medical Group Visits for Managing Chronic Pain1R44AT012302-01A1 | GARDINER, PAULA MARIEHAAS, NIINA M. | BRIGHTOUTCOME INC., IL | $747,191 | ZRG1 |
| 2023 | Transforming Hospitalizations of Autistic Adolescents via a Novel ABA Telehealth Platform1R44MH134706-01 | OBERLEITNER, RONALD | CARING TECHNOLOGIES, INC., ID | $740,782 | ZRG1 |
| 2023 | Sonodynamic therapy using MRI-guided focused ultrasound in combination with 5-aminolevulinic acid to treat recurrent glioblastoma multiforme1R44CA275508-01A1 | MARCUS, STUART | SONALASENSE INC, CA | $694,814 | ZRG1 |
| 2023 | Reducing Hypertension among African American Men: A Mobile Stress Management Intervention to Address Health Disparities2R44MD017106-02 | LEAF, SAMANTHA L. | ISA ASSOCIATES, INC., VA | $693,481 | ZRG1 |
| 2023 | Phase 2 clinical trial of a novel T cell therapy following bridging therapy with hypomethylating agents for relapsed AML patients post-stem cell transplant1R44CA285177-01 | ANGELO, LAURA SVERA, JUAN FERNANDO | MARKER THERAPEUTICS, INC., TX | $664,838 | ZRG1 |
| 2023 | Video observed therapy to enhance flexibility and reduce in-person visits for patients treated with methadone in a multi-site opioid treatment program2R44DA053081-02 | HALLGREN, KEVIN A.SEIGUER, SEBASTIANTSUI, JUDITH | EMOCHA MOBILE HEALTH, INC., MD | $654,494 | ZRG1 |
| 2023 | ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness)1R44HL169085-01 | CREARY, SUSANSEIGUER, SEBASTIAN | EMOCHA MOBILE HEALTH, INC., MD | $642,844 | ZRG1 |
| 2023 | SBIR, Innovative Immersive Technologies for Evidence-Based Violence Prevention among College Students2R44CE003173-02A1 | WILLIAMS, CHRISTOPHER | NATIONAL HEALTH PROMOTION ASSOCIATES, NY | $615,917 | ZRG1 |
| 2023 | Digital Delivery of Evidence-Based Mental Health Content and Mentoring to Adolescents1R44MH134733-01 | PULLMANN, MICHAEL DAVIDROUNDFIELD, KATRINA | APPA HEALTH INC, CA | $558,383 | ZRG1 |
| 2023 | Home Monitoring of Metabolic Disorders1R44HD112243-01 | THOMAS, MARYLAURA LIND | SEQUITUR HEALTH CORP., AZ | $542,100 | ZRG1 |
| 2023 | A Novel Immunological-Directed Biotherapy for Treating Rheumatoid Arthritis1R44AG084484-01 | FANGER, GARY | RISE THERAPEUTICS, LLC, MD | $494,488 | ZRG1 |
| 2023 | Advanced CLAD PERG system with minimal patient preparation for clinical settings (Phase II)2R44EY029620-02A1 | TOFT-NIELSEN, JONATHON ANTHONY | JORVEC CORPORATION, FL | $479,128 | ZRG1 |
| 2023 | Development of an empathetic chatbot to monitor perinatal mental health longitudinally1R43MH130293-01A1 · under PA-21-260 | KERPPOLA, MARIANNAMUZIK, MARIA | POISERA, INC., MI | $431,081 | ZRG1 |
| 2023 | Technology Assisted Treatment for Binge Eating Behavior1R43MH132180-01 · under PA-21-260 | KUMAR, SAMEERPETERSON, CAROL B. | HABITAWARE, INC., MN | $420,178 | ZRG1 |
| 2023 | A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer (mCRPC)1R44CA278187-01A1 | SCHULER, AARON DZEBALA, JOHN A | SYNTRIX BIOSYSTEMS, INC., WA | $400,000 | ZRG1 |
| 2023 | On Demand Oral Contraception for Obese Women1R43HD107861-01A1 | ARCHER, DAVID FITZGERALD | INNOVAGYN, INC., VA | $382,402 | ZRG1 |
| 2023 | SafeMedWaste At-Home, Environmentally-Friendly Opioid Disposal Kit for Orthopedic Post-Operative Surgical Patients to Reduce Opioids Available for Diversion1R43DA057750-01A1 | JACKSON, J. BENJAMINSTAS, JUSTIN | OKRA MEDICAL, INC., SC | $323,698 | ZRG1 |
| 2023 | iKinnect Mobile Technology to Reduce Teen Substance Misuse and Health Disparities1R44DA057122-01 · under PA-21-260 | DIMEFF, LINDA ASCHAEFFER, CINDY M. | EVIDENCE-BASED PRACTICE INSTITUTE, INC., WA | $319,737 | ZRG1 |
| 2023 | Otis Brux-Sensor Night Guard - a novel wireless custom night guard system with pressure sensors to quantitatively measure bite compression forces and alleviate sleep bruxism1R43HL168988-01A1 | BERANEK, RICHARDLEE, ANDREW | OTIS DENTAL, LLC, CA | $299,753 | ZRG1 |
| 2023 | Using Digital Health Technology to Prevent Bullying and Cyberbullying among Elementary School Students1R44HD114361-01 | WILLIAMS, CHRISTOPHER | NATIONAL HEALTH PROMOTION ASSOCIATES, NY | $296,231 | ZRG1 |
| 2023 | Beat Extreme: An Interactive, Tailored Text Messaging Program Combining Extreme Weather Alerts with Hyper-localized Resources & Actionable Insights for Addressing Climate Change1R43ES035344-01 | JOHNSON, SARA S | PRO-CHANGE BEHAVIOR SYSTEMS, INC., RI | $295,923 | ZRG1 |
| 2023 | Apto-Ankle: Passive, Compliant Ankle with Enhanced Energy Storage and Return in Gait1R43HD114307-01 | ARABIAN, ADAM KAREKIN | ORTHOCARE INNOVATIONS, LLC, WA | $293,514 | ZRG1 |
| 2023 | Promoting Parallel Parenting: Putting Children First during High-Conflict Divorce and Separation (PCF)1R44HD111084-01A1 | JONES, JEREMY AUSTINPENNEFATHER, JORDANRUDD, BRITTANY NWENDT, ADAM JOHN | IRIS MEDIA, INC., OR | $288,072 | ZRG1 |
| 2023 | A ratcheting pediatric prosthetic finger using advanced rapid manufacturing technology1R44HD113485-01A1 | SLIKER, LEVIN | POINT DESIGNS, LLC, CO | $275,764 | ZRG1 |
| 2023 | Rumbo: An Integrated Mobile and Web-Based Application to Overcome Barriers to Receive Substance Use Disorder (SUD) Treatment and Improve Outcomes for Spanish-Speaking, Hispanic and Latinx Individuals1R43DA057759-01 · under PA-21-260 | CAMPBELL, WILLIAM P | VOLVER HEALTH LLC, NM | $275,743 | ZRG1 |
| 2023 | Clarity in Motion: A Motion-Tolerant Aid for Selectively Hearing Acoustic Sources1R43DC020690-01A1 · under PA-21-260 | GOLDHOR, RICHARD S | SPEECH TECHNOLOGY/APPLIED RESEARCH CORP., MA | $275,389 | ZRG1 |
| 2023 | Voice-based AI to scale evaluation of crisis counseling in 988 rollout1R44MH133517-01 | ATKINS, DAVID CHARLES | LYSSN.IO, INC., WA | $275,373 | ZRG1 |
| 2023 | DEVELOPMENT OF A NOVEL PEER RECOVERY SUPPORTER TRAINING PLATFORM TO DISSEMINATE EVIDENCE-BASED TRAINING AT SCALE1R44AA030953-01A1 | PESCE, CHRISTOPHER NEIL | THRIVE DIGITAL HEALTH, LLC, OH | $275,301 | ZRG1 |
| 2023 | Biomechanical Evaluation of a Novel, Compliant Low Profile Prosthetic Foot1R43HD110316-01A1 | BARTLETT, HARRISON LOGAN | LITTLE ROOM INNOVATIONS, LLC, MI | $275,197 | ZRG1 |
| 2023 | Tele-FootX: Virtually Supervised Tele-Exercise Platform for Accelerating Plantar Wound Healing1R43AG082614-01 | NAJAFI, BIJANVAZIRI, ASHKAN | BIOSENSICS, LLC, MA | $275,000 | ZRG1 |
| 2023 | A Translational Research Approach to Healthy Technology Usage in Language-Minority Families with Young Children1R44HD114323-01 | TURCO, ROSA GUZMAN | TRANSCENDENT INTERNATIONAL, LLC, NY | $274,996 | ZRG1 |
| 2023 | Development and Evaluation of the PPAL Bedside Commode for Safe Independent Toileting Transfers2R44NR019516-02A1 | GRAHAM, MARGARET ELLEN | QUA, INC., NY | $273,056 | ZRG1 |
| 2023 | Previvors Recharge: A Resilience Program for Cancer Previvors1R43CA275673-01A1 | EVERS, KERRY | PRO-CHANGE BEHAVIOR SYSTEMS, INC., RI | $265,253 | ZRG1 |
| 2023 | Fast-Track Multimodal monitoring for neonatal neurocritical care1R44HD107729-01A1 · under PA-21-260 | CARNES, TONY CHRIS | MEDITRACE LLC, FL | $260,434 | ZRG1 |
| 2023 | Humidifeye Plug for Dry Eye Disease1R44EY034758-01 · under PA-21-260 | BAYAT, NIKI | AESCULATECH, INC., CA | $250,487 | ZRG1 |
| 2023 | LIMBER UniLeg: A digital and additive manufacturing approach for accessible prosthetic care.1R43HD112285-01A1 | BARRACK, HERBERT JOSEPH | LIMBER PROSTHETICS & ORTHOTICS INC., CA | $247,429 | ZRG1 |
| 2022 | Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder2R44AA024905-06 · under PA-20-262 | TABAKOFF, BORIS | LOHOCLA RESEARCH CORPORATION, CO | $1,710,532 | ZRG1 |
| 2022 | Augmented Reality Real-Time Guidance for MRI-Guided Interventions2R44EB028722-02A1 · under PA-21-260 | RAJAN, PURNIMA | CLEAR GUIDE MEDICAL, INC., MD | $1,561,929 | ZRG1 |
| 2022 | Labor Status Monitor for diagnosing True versus False Labor in preterm patients1R44HD109107-01 · under PA-21-260 | YOUNG, ROGER C. | PRETEL, INC., TN | $1,375,524 | ZRG1 |
| 2022 | Assessing the Utility of Submaximal Cardiopulmonary Exercise Testing in Diagnosis and Treatment Management of Pulmonary Arterial Hypertension1R44HL162169-01A1 · under PA-21-260 | MACCARTER, DEAN JUDSON | SHAPE MEDICAL SYSTEMS, INC., MN | $1,223,664 | ZRG1 |
| 2022 | Improving lung cancer surgery with an intraoperative, tumor-targeted, activatable fluorescent imaging agent1R44CA277890-01 · under PA-21-260 | BENSEN, ERIC SCOTTSINGHAL, SUNIL | VERGENT BIOSCIENCE, INC., MN | $1,124,282 | ZRG1 |
| 2022 | An Open-source Speech Processing Platform (OSP) for Research on Hearing Loss and Related Disorders1R44DC020406-01 · under PA-21-260 | GARUDADRI, HARINATH | NADI LLC, CA | $1,112,006 | ZRG1 |
| 2022 | Evaluation of Subtractive Immunopheresis for Treatment of Hormone-Refractive Advanced Breast Cancer1R44CA261565-01A1 · under PA-21-260 | SHENOUDA, CHRISTIAN | IMMUNICOM, INC., CA | $1,072,330 | ZRG1 |
| 2022 | Development of Sotair for Improving Performance and Minimizing Complications of Manual Ventilation1R44HL165932-01A1 · under PA-21-260 | PRABHUDESAI, PRATHAMESH | SAFEBVM CORP., MO | $1,054,335 | ZRG1 |
| 2022 | Improving the health status of dysvascular amputees by deploying digital prosthetic interface technology in combination with exercise intervention1R44HD110327-01 · under PA-21-260 | BONATO, PAOLOTURNER, TROY | BIONIC SKINS LLC, NH | $1,052,841 | ZRG1 |
| 2022 | Active Disposable Cap for Endoscope Tip Stabilization and Complete Visualization and Dissection of Serrated Sessile Polyps2R44DK117813-06 · under PA-21-260 | MULVIHILL, MAUREEN L. | ACTUATED MEDICAL, INC., PA | $1,047,462 | ZRG1 |
| 2022 | IND‐enabling development of MM‐008 IVR, an antibody-based nonhormonal contraceptive intravaginal ring1R44HD107824-01 · under PA-20-262 | CONE, RICHARD | MUCOMMUNE, LLC, NC | $1,039,122 | ZRG1 |
| 2022 | A Phase 1b, Open-Label, Study of a Novel Targeted Radiotherapy in Children, Adolescents and Young Adults with Inoperable Relapsed or Refractory High Grade Glioma1R44CA272070-01A1 · under PA-21-260 | LONGCOR, JARRODREILLY, LAURENCE | CELLECTAR BIOSCIENCES, INC., NJ | $1,034,797 | ZRG1 |
| 2022 | Portable, Patient-Administered Scalp Cooling Cap to Reduce Provider Burden, Improve Patient Access, and Improve Patient Outcomes for Chemotherapy-Induced Alopecia2R44CA254560-02 · under PA-21-260 | DILLIGAN, KATE | COOLER HEADS CARE INC, CA | $1,033,003 | ZRG1 |
| 2022 | PROGRESS: PRevention of cervical cancer using the Genotyping scREening and Same-day Self-sampling1R44CA272177-01 · under PA-21-260 | CREMER, MIRIAMWANG, YOUXIANG | ATILA BIOSYSTEMS, INC., CA | $1,011,310 | ZRG1 |
| 2022 | StrokeWear: A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Home Daily Life.2R44HD084035-04 · under PA-21-260 | BONATO, PAOLOKEYSOR, JULIE JVAZIRI, ASHKAN | BIOSENSICS, LLC, MA | $1,008,134 | ZRG1 |
| 2022 | A novel enteral feeding system for the earlier and safer delivery of enteral nutrition through continuous monitoring of tip location1R44AG076248-01A1 · under PA-21-260 | BURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $1,004,449 | ZRG1 |
| 2022 | Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer1R44CA265626-01A1 · under PA-21-260 | LI, YAJUANTWEEDLE, MICHAEL F | MOLECULAR THERANOSTICS, LLC, OH | $1,000,000 | ZRG1 |
| 2022 | Expedited Expansion Cohort Clinical Trial for Relapsed/Refractory 'no-option' Non-Hodgkin's Lymphoma/Leukemia Patients1R44CA272096-01 · under PA-21-260 | DEISHER, THERESA | AVM BIOTECHNOLOGY, LLC, WA | $999,999 | ZRG1 |
| 2022 | Early clinical development of a novel IL-7R antibody for treating children with relapsed T-cell leukemia1R44CA268530-01A1 · under PA-21-260 | BREITFELD, PHILIPVARADHACHARY, ATUL | FANNIN PARTNERS, LLC, TX | $999,997 | ZRG1 |
| 2022 | Ceraxa (Ceramide NanoLiposome) and Vinblastine For the Improved Treatment of Relapsed or Refractory Acute Myeloid Leukemia1R44CA275609-01 · under PA-21-260 | ADAIR, BERNADETTE MCMAHON | KEYSTONE NANO, INC., PA | $999,628 | ZRG1 |
| 2022 | A treatment drug for triple negative breast cancer1U44CA268345-01A1 · under PA-21-260 | LIU, ZHI-REN | PRODA BIOTECH, LLC, GA | $999,562 | ZRG1 |
| 2022 | The HOPE App: An Immersive Telehealth Solution for Older Adults with Diabetes2R44AG072990-02 · under PA-21-260 | MITCHELL, SUZANNE | SEE YOURSELF HEALTH, LLC, MA | $997,968 | ZRG1 |
| 2022 | Demonstration of the Feasibility of Closed Loop Control of Blood Glucose in the Intensive Care Unit Setting Using a Novel Artificial Intelligence Based Glucose Control System1R44DK133084-01 · under PA-21-260 | DEJOURNETT, LEON | IDEAL MEDICAL TECHNOLOGIES, INC., NC | $958,212 | ZRG1 |
| 2022 | Evaluation of the safety and efficacy of non-invasive sonodynamic therapy for diffuse intrinsic pontine glioma1R44CA261516-01A1 · under PA-20-262 | MARCUS, STUART | SONALASENSE INC, CA | $938,955 | ZRG1 |
| 2022 | Knowledge and Usage of Lactation using Education and Advice from Support Network (KULEA-NET)1R44MD016829-01A1 · under PA-21-260 | EVANS, W. DOUGLASMA, TONY XUYENPATCHEN, LORAL | BENTEN TECHNOLOGIES, INC., VA | $915,801 | ZRG1 |
| 2022 | PeriPath: A Single Incision Delivery Tool for Epicardial Pacing and Defibrillation: Phase 21R44HL166048-01 · under PA-21-260 | BERUL, CHARLES IOPFERMANN, JUSTIN | PERICOR, LLC, MD | $914,055 | ZRG1 |
| 2022 | Citizen-Science Technology for Healthy Living at Home2R44MD014915-02 · under PA-21-260 | CARTER, ELLISON MREILLY, THOMAS | ACCESS SENSOR TECHNOLOGIES, LLC, CO | $882,648 | ZRG1 |
| 2022 | Technology Assisted Treatment for Trichotillomania2R44MH114773-03 · under PA-20-262 | FLESSNER, CHRISTOPHER A.KUMAR, SAMEER | HABITAWARE, INC., MN | $879,144 | ZRG1 |
| 2022 | MyRareDiet: A Diet Tracking, Monitoring and Optimization mHealth Solution for Patients with Inborn Errors of Metabolism1R44HD107766-01A1 · under PA-21-260 | HOOK, DEBRA GEARYYANG, DERSHUNG | BRIGHTOUTCOME INC., IL | $870,262 | ZRG1 |
| 2022 | Enhancing the Effectiveness of Community Health Workers to Reduce Cervical Cancer Disparities in African American Women2R44MD015221-02A1 · under PA-21-260 | BILLINGS, DOUGLAS W | ISA ASSOCIATES, INC., VA | $855,861 | ZRG1 |
| 2022 | Phase 1 Study of DNX-2440 for Resectable Colorectal Liver Metastasis - IND 0185691R44CA268421-01A1 · under PA-21-260 | ROBBINS, JOAN MARIE | DNATRIX, INC., CA | $852,568 | ZRG1 |
| 2022 | Modular Convertible Child Safety Seat to Improve Usage2R44HD096963-02A1 · under PA-20-262 | RYDBERG, NICK | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $848,654 | ZRG1 |
| 2022 | Step UP for STEM and Health Careers: An Intervention to Reduce STEM-related biases and improve high school STEM learning environments2R44HD103517-02 · under PA-20-262 | GILLIAM, MELISSA L.HOLL, JANE LOUISEPARSONS, TIMOTHY | RESILIENT GAMES STUDIO, LLC, IL | $834,357 | ZRG1 |
| 2022 | Preventing prescription opioid misuse among employees working in high risk industries.2R44DA050404-02 · under PA-21-260 | HEBARD, STEPHEN | PREVENTION STRATEGIES, LLC, NC | $832,786 | ZRG1 |
| 2022 | Home-Based Parent-Child Intervention to Enhance Executive Function2R44MH121664-02A1 · under PA-21-260 | ANDERSON, SHANE M. | KORONIS BIOMEDICAL TECHNOLOGIES CORPORAT, MN | $811,481 | ZRG1 |
| 2022 | SonoHeal: Smart Resonating Closed-loop Airway Clearance Technology2R44HL152912-02A1 · under PA-20-262 | BISWAS, RAJOSHI | COGNITA LABS, LLC, CA | $780,162 | ZRG1 |
| 2022 | Family Therapy Training and Implementation Platform (FTTIP): An innovative web-based tool for long-term practice improvement2R44MH115547-02 · under PA-21-260 | SANTISTEBAN, DAVID | TRAINING AND IMPLEMENTATION ASSOCIATES, LLC, FL | $752,595 | ZRG1 |
| 2022 | hANDY-i(TM): A non-invasive, dual-sensor handheld imager for intraoperative preservation of parathyroid glands2R44EB030874-02 · under PA-21-260 | CHA, RICHARD JAEPYEONGOH, EUGENERUSSELL, JONATHON O | OPTOSURGICAL, LLC, DE | $749,839 | ZRG1 |
| 2022 | Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG)1R44DK131708-01A1 · under PA-21-260 | PERLSTEIN, ETHAN | MAGGIE'S PEARL, LLC, MI | $699,884 | ZRG1 |
| 2022 | Comadres Saludables: A Web-Based Promotora Training Program for Obesity Prevention in Hispanic Women2R44MD016228-02 · under PA-21-260 | RIOS, DEBRA | ISA ASSOCIATES, INC., VA | $697,188 | ZRG1 |
| 2022 | Acuity - A Clinical Decision Support System for Applied Behavior Analysis1R44MH131510-01 · under PA-21-260 | JAKOBOVITS, REX M | EXPERIAD, LLC, HI | $679,957 | ZRG1 |
| 2022 | Ocular Blood Flow Imaging for Glaucoma Assessment1R44EY034064-01 · under PA-21-260 | REGE, ABHISHEK | VASOPTIC MEDICAL, INC., MD | $674,883 | ZRG1 |
| 2022 | Phenotyping Interstitial Cystitis/Bladder Pain Syndrome by ICE-MRI Based Bladder Permeability Assay2R44DK108397-04 · under PA-21-260 | KAUFMAN, JONATHAN H | LIPELLA PHARMACEUTICALS, INC., PA | $673,049 | ZRG1 |
| 2022 | Adaptive & Individualized AAC2R44DC018437-02A1 · under PA-21-260 | VOJTECH, JENNIFER MICHELE | ALTEC, INC., MA | $575,701 | ZRG1 |
| 2022 | Remote STATE training for Insomnia in Older Adults1R44AG076304-01 · under PA-20-262 | VANVLEET, THOMAS | POSIT SCIENCE CORPORATION, CA | $534,429 | ZRG1 |
| 2022 | Clinical Studies for Improving Survival Rates for Oral Cancer Patients in Low Resource Settings1R44CA272095-01 · under PA-21-260 | GOLDBERG, MANIJEH NKEITH, DONNA | PRIVO TECHNOLOGIES, LLC, MA | $401,107 | ZRG1 |
| 2022 | Modulation of cancer induced immune suppression via inhibition of SCD11R44CA272064-01A1 · under PA-21-260 | COPLAND, JOHN A.HAYES, KAREN ETAN, WINSTON | MODULATION THERAPEUTICS, INC., WV | $399,986 | ZRG1 |
| 2022 | EaseAlert: Tactile Firefighter Alerting System Designed to Reduce Negative Cardiovascular Outcomes and Sleep Disturbances1R43HL164225-01A1 · under PA-21-260 | BILLINGS, JOELRICHARDSON, BLAKE | EASEALERT LLC, FL | $384,782 | ZRG1 |
| 2022 | A Novel Immunological-Directed Live Biotherapy Product for Treating Ulcerative Colitis1R44DK133061-01A1 · under PA-21-260 | FANGER, GARY | RISE THERAPEUTICS, LLC, MD | $360,624 | ZRG1 |
| 2022 | Development of novel Aquilo Heat Therapy Device to treat patients with PeripheralArtery Disease1R43HL162337-01A1 · under PA-21-260 | SPENCE, PAUL | AQUILO SPORTS, LLC, KY | $350,681 | ZRG1 |
| 2022 | A Mobile Text Approach to Measurement and Feedback for Wraparound Care Coordination1R43MH126793-01A1 · under PA-20-262 | BRUNS, ERIC J.DEROSIER, MELISSA E. | 3-C INSTITUTE FOR SOCIAL DEVELOPMENT, NC | $328,220 | ZRG1 |
| 2022 | Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.1R44DA057133-01 · under PA-21-260 | PERGOLIZZI, JOSEPH V | ENALARE THERAPEUTICS INC., NJ | $319,703 | ZRG1 |
| 2022 | Clinical study of a wearable therapeutic ultrasound sleeve for treatment of neuro-ischemic and ischemic diabetic foot ulcers1R43DK131707-01 · under PA-20-262 | ELSTAD, JULIANA | VIBRATO MEDICAL, INC., CA | $300,000 | ZRG1 |
| 2022 | Improving physical function and quality of life in older adults with prediabetes utilizing interactive small-group resistance training through video conference technology1R44AG076087-01 · under PA-20-262 | LEVITAN, ERICSTARR, KATHRYN N | IMPACTIV, INC., GA | $300,000 | ZRG1 |
| 2022 | Non-invasive therapeutic ultrasound device for treatment of peripheral arterial disease in elderly population1R44AG076190-01A1 · under PA-21-260 | ELSTAD, JULIANA | VIBRATO MEDICAL, INC., CA | $300,000 | ZRG1 |
| 2022 | Smart Technology to Empower Collaborative Partnerships Among Behavior Practitioners and Caregivers to Deliver Quality ABA1R43MH130298-01 · under PA-21-260 | NOSEK, JOHN | GUIDING TECHNOLOGIES CORPORATION, PA | $297,785 | ZRG1 |
| 2022 | Novel Myofunctional Therapy Water Bottle to Reduce Obstructive Sleep Apnea and Snoring1R43HL160368-01A1 · under PA-20-262 | OLMANSON, ANDERS | REMASTERED SLEEP LLC, MN | $293,675 | ZRG1 |
| 2022 | Promoting Linguistic and Cultural Identity through Bilingual Children's Stories to Address Nutrition and Health in Indigenous Communities1R44MD017552-01 · under PA-21-260 | RIESTENBERG, KATHERINE | TRANSCENDENT INTERNATIONAL, LLC, NY | $292,201 | ZRG1 |
| 2022 | Identification of mechanism-based therapies to treat arrhythmogenic cardiomyopathy by resolving perturbations in regulatory lipid signaling1R43HL164226-01 · under PA-21-260 | CORTES-PUCH, IRENE | EICOSIS, LLC, CA | $279,136 | ZRG1 |
| 2022 | Novel Stimulation to Improve Respiratory Function in ARDS and Severe COVID-19 Patients1R43HL162180-01A1 · under PA-21-260 | HARDIN, BILLLU, DANIEL | RESTORE TECHNOLOGIES, INC., CA | $275,405 | ZRG1 |
| 2022 | A Telehealth Intervention to Increase Screening and Treatment for Alcohol Use Disorder1R44AA030702-01 · under PA-21-260 | MENDELSON, JOHN E. | RIA TECHNOLOGY MANAGEMENT INC., CA | $267,065 | ZRG1 |
| 2022 | ID-Cap System: Next generation ingestible sensors for medication adherence measurement1R43NR020289-01A1 · under PA-21-260 | CARNES, TONY CHRISCHAI, PETER R | ETECTRX, INC., FL | $259,270 | ZRG1 |
| 2022 | Access-H20: Sensor driven smart faucet to enable and empower independent drinking and grooming for individuals impacted by spinal cord injury1R43HD108061-01A1 · under PA-21-260 | WADDELL, JOHN STEVEN | NASONI LLC, VA | $259,015 | ZRG1 |
| 2022 | Improving high-risk infant care: from Hospital to Home with Neoneur Telehealth1R44NR020275-01 · under PA-20-262 | HOEDEMAKER, CAROLINE | NEONEUR LLC, NJ | $256,579 | ZRG1 |
| 2022 | A comprehensive web-based program to help advanced cancer patients plan for end of life1R44NR020341-01 · under PA-20-262 | GOOD, JENNIFERSHEN, MEGAN JOHNSON | PEACEFULLY, INC., CA | $256,065 | ZRG1 |
| 2022 | Intervention to Help Orient Men to Excel (IN-HOME): A culturally appropriate CHW training program to reduce minority caregiver burden1R43MD018249-01 · under PA-21-260 | COOPER, DEXTER L | KDH RESEARCH AND COMMUNICATION, INC., GA | $251,624 | ZRG1 |
| 2022 | Engage-Rx a web-based clinical decision support tool for management of hypertension through patient engagement and automated algorithmic clinical decision support1R43DP006817-01 · under PA-21-260 | FONTIL, VALY | ENGAGE RX, INC., CA | $245,159 | ZRG1 |
| 2022 | Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals (EDCs) in Women of Child-Bearing Age and their Partners1R43ES034312-01 · under PA-21-260 | HUA, JENNA | MILLION MARKER WELLNESS INC., CA | $218,790 | ZRG1 |
| 2022 | Civamide Nasal Spray for the Treatment of Dry Eye1R43EY033606-01 · under PA-20-262 | PHILLIPS, SCOTT | ELORAC, INC., IL | $160,284 | ZRG1 |
| 2022 | Joyuus: A Web-based Tool for Postpartum Care Self-care to Address the Complex Needs of Underserved Women2R44MD014923-02 · under PA-21-260 | MARCEAU, LISA DMERZ, KRISTINE | ORANGE SQUARE DESIGN, INC., RI | $1 | ZRG1 |
| 2021 | Using Clinical Treatment Data in a Machine Learning Approach for Sepsis Detection2R44AA030000-02 · under PA-20-262 | HOFFMAN, JANA | DASCENA, INC., CA | $1,999,554 | ZRG1 |
| 2021 | Clinical Trial and Commercialization of a Wearable Therapeutic Ultrasound Device for Peripheral Arterial Disease1R44HL156543-01 · under PA-19-273 | DAW, DEREK | VIBRATO MEDICAL, INC., CA | $1,500,000 | ZRG1 |
| 2021 | Novel α2-Antiplasmin Inactivation for Lysis of Intravascular Thrombi (NAIL-IT) Trial1R44HL158376-01 · under PA-20-262 | JEONG, SUN YONGREED, GUY LTAPSON, VICTOR F. | TRANSLATIONAL SCIENCES, INC., AZ | $1,408,991 | ZRG1 |
| 2021 | Assessing the safety and efficacy of SQ3370 in a phase 1b dose-expansion cohort at the recommended Phase 2 dose in patients with advanced sarcoma1R44CA265665-01 · under PA-20-262 | MEJIA ONETO, JOSE M | SHASQI, INC., CA | $1,376,786 | ZRG1 |
| 2021 | A first in human clinical study of TT101, a synthetic immunomodulatory material to build new functional tissue over exposed bone as a one time treatment for diabetic limb preservation patients1R44DK130778-01 · under PA-20-262 | DESHAYES, STEPHANIE | TEMPO THERAPEUTICS, INC., CA | $1,368,090 | ZRG1 |
| 2021 | Immune Biomarker Assessment and Manufacturing Development for SQ3370-001, a first-in-human phase I dose-escalation clinical trial to test a novel treatment against advanced solid tumors1R44CA261573-01 · under PA-20-262 | MEJIA ONETO, JOSE M | SHASQI, INC., CA | $1,198,848 | ZRG1 |
| 2021 | Manganese Based MRI Contrast Agent - First In Human Clinical Trial1R44CA268392-01 · under PA-20-262 | HOFFMAN, VERA | REVEAL PHARMA, MA | $1,149,940 | ZRG1 |
| 2021 | Clinical investigation of topical delivery of a muscarinic receptor antagonist for the prevention of chemotherapy-induced peripheral neuropathy1R44CA265565-01 · under PA-20-262 | HANSEN, ANGELA | WINSANTOR, INC., CA | $1,101,366 | ZRG1 |
| 2021 | Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer1R44CA257278-01A1 · under PA-20-262 | PACK, CHRISTOPHER D | METACLIPSE THERAPEUTICS CORPORATION, GA | $1,061,403 | ZRG1 |
| 2021 | Randomized phase II study of TheraBionic in advanced hepatocellular carcinoma1R44CA256984-01A1 · under PA-20-262 | PASCHE, VALERIE | THERABIONIC INC., NC | $1,059,091 | ZRG1 |
| 2021 | QBS10072S for the Treatment of Brain Metastatic Triple-Negative Breast Cancer1R44CA257579-01A1 · under PA-20-262 | RINGOLD, GORDON M | QUADRIGA BIOSCIENCES, INC., CA | $1,053,136 | ZRG1 |
| 2021 | Patient tailored near real-time image-based treatment for interstitial PDT of Inoperable Cancer with Airway Obstruction - Phase IIa1R44CA265656-01 · under PA-20-262 | POTASEK, MARYSHAFIRSTEIN, GAL | SIMPHOTEK, INC., NJ | $1,050,000 | ZRG1 |
| 2021 | Clinical Feasibility of Wireless Catheter-Free Urodynamics for Extended, Comprehensive Urological Evaluation in the Home Setting1R44DK131700-01 · under PA-20-262 | HERRERA, DEREK | BRIGHT URO, INC., CA | $999,992 | ZRG1 |
| 2021 | A Phase 1, Open Label, Multicenter Trial to Assess the Safety, Tolerability and Efficacy of MB-106 in Patients with Relapsed or Refractory CD20+ B-Cell NHL or CLL1R44CA265616-01 · under PA-20-262 | LITCHMAN, MANUEL | MUSTANG BIO, INC., MA | $999,336 | ZRG1 |
| 2021 | Phase 1/2a Clinical Study of Descartes-30 in Acute Respiratory Distress Syndrome1R44HL158446-01 · under PA-20-262 | STEWART, CHARLES ANDREW | CARTESIAN THERAPEUTICS, INC., MD | $998,742 | ZRG1 |
| 2021 | Transformation of Dormant Spinal Networks to Mitigate Symptoms of Neurogenic Bladder1R44DK129164-01A1 · under PA-20-262 | GAD, PARAG | SPINEX, INC., CA | $956,407 | ZRG1 |
| 2021 | Electrical stimulation to reduce pain and improve function after knee replacement2R44AG052196-04A1 · under PA-20-262 | BOGGS, JOSEPH WILDER | SPR THERAPEUTICS, LLC, OH | $954,397 | ZRG1 |
| 2021 | IndieTrainer: Enabling Children with Cerebral Palsy to Receive Gamified Power Mobility Training in their Own Manual Wheelchairs1R44HD103522-01A1 · under PA-20-262 | ZONDERVAN, DANIEL | FLINT REHABILITATION DEVICES, CA | $954,242 | ZRG1 |
| 2021 | Soft Spring Continence Pessary for Women1R44HD105574-01 · under PA-20-262 | GAUPP, CHRISTINAROBERTS, MELODY ANN | LIV LABS INC., IL | $951,491 | ZRG1 |
| 2021 | Zip-stitch for Laparoscopic Hysterectomy - Clinical Validation1R44HD104539-01A1 · under PA-20-262 | MAZZUCCO, DAN C | ZSX MEDICAL, LLC, PA | $928,014 | ZRG1 |
| 2021 | Non-Invasive Neuromodulation Device for the Treatment of Alcohol Use Disorder2R44AA027188-02 · under PA-20-262 | BATKI, STEVEN LBURNETT, DANIEL ROGERS | THERANOVA, LLC, CA | $910,489 | ZRG1 |
| 2021 | Fostering Caregiver Connections via Intentional Technology Pairing for Caregivers of Patients with Alzheimer's Disease and Other Types of Dementia2R44AG065088-02 · under PA-20-262 | KRAMER, KEVIN M. | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $909,966 | ZRG1 |
| 2021 | Assistive ExoSkeleton and ExoTendon System for Increased Return of Limb Function after Diabetic Foot Ulcer1R44NR019969-01 · under PA-20-262 | ROSER, MARK C | RESULTS GROUP, CT | $870,416 | ZRG1 |
| 2021 | Boost: A pragmatic inpatient rehabilitation strategy for improving musculoskeletal arm recovery after stroke1R44HD106850-01 · under PA-20-262 | ZONDERVAN, DANIEL | FLINT REHABILITATION DEVICES, CA | $868,802 | ZRG1 |
| 2021 | DreamPort-Eclipse: Compact, ultra-low contact, custom fit CPAP human interface solution for obstructive sleep apnea1R44HL158286-01A1 · under PA-20-262 | HEATHERINGTON, STUART | BLEEP, LLC, NC | $860,622 | ZRG1 |
| 2021 | Safety-Enhancing Motor Vehicle Child Safety Seat2R44CE003388-02 · under PA-20-262 | RYDBERG, NICK | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $846,699 | ZRG1 |
| 2021 | Socializing a Science-based Digital Therapeutic for Substance Use Disorders2R44DA047150-02 · under PA-20-262 | GRABINSKI, MICHAEL JOHN | SQUARE2 SYSTEMS, INC., NH | $836,571 | ZRG1 |
| 2021 | Utility of Esophageal Cooling Therapy for the Prevention of Thermal Injury During Atrial Fibrillation1R44HL158375-01 · under PA-20-262 | KULSTAD, ERIK BENJAMINSANTANGELI, PASQUALETSCHABRUNN, CORY MICHAEL | ADVANCED COOLING THERAPY, LLC, IL | $800,000 | ZRG1 |
| 2021 | An Open-Label, Multicenter, Phase 2/3 Efficacy and Safety Study of a targeted radiotherapy in Patients with Relapsed or Refractory Waldenstroms Macroglobulinemia1R44CA265558-01 · under PA-20-262 | FRIEND, JOHNLONGCOR, JARROD | CELLECTAR BIOSCIENCES, INC., NJ | $763,080 | ZRG1 |
| 2021 | RT Assistant - handheld patient safety tool for mechanical ventilation2R44HL146012-02A1 · under PA-20-262 | EULIANO, NEIL R. | CONVERGENT ENGINEERING, INC., FL | $756,143 | ZRG1 |
| 2021 | Ambient light activatable opsin based therapy for age-related macular degeneration2R44EY025905-04 · under PA-20-262 | MOHANTY, SAMARENDRA KUMAR | NANOSCOPE TECHNOLOGIES, LLC, TX | $749,517 | ZRG1 |
| 2021 | A Video-Based mHealth Program to Support People Living with HIV Across the HIV Care Continuum2R44MD013644-02 · under PA-19-273 | MONTOYA, JORGE ALEJANDRO | SENTIENT RESEARCH, INC., CA | $744,090 | ZRG1 |
| 2021 | Reducing Colorectal Cancer Health Disparities: An mHealth Intervention to Improve Screening among African American Men2R44CA246899-02A1 · under PA-20-262 | LEAF, SAMANTHA L. | ISA ASSOCIATES, INC., VA | $723,593 | ZRG1 |
| 2021 | Device to Deliver Intra-Operative Therapeutic Hypothermia for Hearing Preservation in Cochlear Implantation1R44DC019586-01 · under PA-20-262 | KING, CURTIS SCOTTRAJGURU, SUHRUD M. | RESTOREAR DEVICES, LLC, MT | $712,765 | ZRG1 |
| 2021 | Strengthening Families Program Online for Teens and Families2R44DA046238-02A1 · under PA-19-273 | KUMPFER, KAROL L. | STRENGTHENING FAMILIES PROGRAM, LLC, UT | $682,065 | ZRG1 |
| 2021 | Technology-based Training Tool for an Empirically-Supported Group-Based HIV and STI Prevention Intervention for Juvenile Offenders2R44MD014113-02 · under PA-20-262 | DONENBERG, GERI RFEIL, EDWARD GUSTAVSMITH, DAVID RANDOLPH | OREGON RES BEHAVIORAL INTERVENTION STRAT, OR | $675,605 | ZRG1 |
| 2021 | Assist-Knee: Energy Harvesting for Sit-to-Stand-to-Sit Transitions2R44HD097826-02A1 · under PA-20-262 | CHANG, SARAH | ORTHOCARE INNOVATIONS, LLC, WA | $665,414 | ZRG1 |
Showing the 200 most recent of 379 awards.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.